Loading...

INBX INHIBRX BIOSCIENCES INC Earnings Reports 8-K Filing

NHBR

NBX

INHIBRX BIOSCIENCES INC

(INBX)

2025 8-K

Financial Results Announced

Clinical Trial Update

Clinical Data Update

Financial Results Announcement

Corporate Presentation Update

Clinical Trial Update

Financial Results Announced

Positive Trial Results

Financial Results Announcement

Financial Statements

Management Changes

Financial Results

Ozekibart Data Release

Financial Results

External Links:

Inhibrx Biosciences, Inc. announced its financial results for Q3 and the nine months ended September 30, 2025, on November 14, 2025. This filing is significant for investors as it provides insights into the company’s financial performance.

AI Assistant

INHIBRX BIOSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.